ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

167
Analysis
Health Care • India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
•08 Oct 2019 00:00

Lucror Analytics - Morning Views Asia - 08 Oct 2019

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
89 Views
Share
•02 Oct 2019 00:00

Asia HY Monthly - Macau Gaming Update - Lucror Analytics

In this month’s In-Focus, we provide an update on the Macau gaming sector, including our market outlook, concession renewals and a peer...

Logo
171 Views
Share
•27 Sep 2019 00:00

Glenmark - Tear Sheet - Lucror Analytics

We view Glenmark Pharmaceuticals as “Medium Risk” on the LARA scale. Our opinion is primarily based on the company’s sound track record of...

Logo
132 Views
Share
•26 Sep 2019 00:00

Asia HY Trade Recommendations - September 2019 - Lucror Analytics

The Asia HY Trade Recommendations report for September includes a summary of our recommendations, as well as our high-conviction ideas. We also...

Logo
177 Views
Share
•18 Sep 2019 00:00

Lucror Analytics - Morning Views Asia - 18 Sep 2019

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
86 Views
Share
x